<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03326960</url>
  </required_header>
  <id_info>
    <org_study_id>dsyy002</org_study_id>
    <nct_id>NCT03326960</nct_id>
  </id_info>
  <brief_title>Sevoflurane and Propofol on POD and POCD</brief_title>
  <official_title>Effects of Anesthetics Sevoflurane and Propofol on Postoperative Delirium (POD) and Postoperative Cognitive Dysfunction (POCD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will perform clinical studies to test the hypothesis that participants who
      have total hip/knee replacement under propofol anesthesia will have less POCD/POD as compared
      to participants who have the surgery under sevoflurane anesthesia, and POCD/POD is associated
      with retinal nerve fiber layer (RNFL) thickness, as well as Serum level of vitamin B12, folic
      acid, homocysteine and human myeloid differentiation protein-2 (MD-2s). The investigators
      plan to perform the studies in 200 participants in Shanghai 10th People's Hospital.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>At 1st day after the surgery</time_frame>
    <description>Postoperative delirium will be determined by Confusion Assessment Method (CAM) at 1st postoperative day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>At 2nd day after the surgery</time_frame>
    <description>Postoperative delirium will be determined by CAM at 2nd postoperative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>At 3rd day after the surgery</time_frame>
    <description>Postoperative delirium will be determined by CAM at 3rd postoperative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative cognitive function</measure>
    <time_frame>Preoperative cognitive function (baseline)</time_frame>
    <description>Preoperative cognitive function will be assessed by neuropsychological battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative cognitive dysfunction</measure>
    <time_frame>At 7th day after the surgery</time_frame>
    <description>Postoperative cognitive dysfunction will be assessed by neuropsychological battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative cognitive dysfunction</measure>
    <time_frame>At 3rd moth after the surgery</time_frame>
    <description>Postoperative cognitive dysfunction will be assessed by neuropsychological battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal nerve fiber layer thickness</measure>
    <time_frame>Before the surgery (baseline)</time_frame>
    <description>Retinal nerve fiberlayer（RNFL）thickness will be measured by optical coherence tomography (OCT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal nerve fiber layer thickness</measure>
    <time_frame>At 3rd month after the surgery</time_frame>
    <description>RNFL thickness will be measured by OCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s)</measure>
    <time_frame>Before the surgery (baseline)</time_frame>
    <description>vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s)</measure>
    <time_frame>At 1st day after the surgery</time_frame>
    <description>vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s)</measure>
    <time_frame>At 4th day after the surgery</time_frame>
    <description>vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s)</measure>
    <time_frame>At 7th day after the surgery</time_frame>
    <description>vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Sevoflurane</condition>
  <condition>Propofol</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <description>Patients in Sevoflurane group are maintained with sevoflurane (1%~4% inhalation), remifentanil (0.1~0.3μg•kg-1•min-1, intravenous administration) and cisatracurium (0.1mg•kg-1•h-1 intravenous administration).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <description>Patients in propofol group are maintained with propofol (1-3μg/ml plasma target controlled infusion), remifentanil (0.1~0.3μg•kg-1•min-1, intravenous administration), and cisatracurium (0.1mg•kg-1•h-1 intravenous administration).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Anesthesia maintenance with sevoflurane+remifentanil guided by Narcrotrend index monitoring.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Anesthesia maintenance with propofol+remifentanil guided by Narcotrend index monitoring.</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The investigators will collect 10ml venous blood before anesthesia, and then 10ml venous
      blood after surgery on Day 1, Day 4 and Day 7, respectively. Serum level of vitamin B12,
      folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients,who had knee or hip fractures and admitted to the Department of Orthopedics in
        Shanghai 10th People's Hospital, were screened and asked to participate in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) class I-Ⅲ

          -  Aged from 60 years to 85 years

          -  Hip/knee surgery under general anesthesia

        Exclusion Criteria:

          -  Alcoholism or drug dependence

          -  Severe psychiatric and neurological diseases

          -  Visual or auditory defects

          -  Inability to understand the language (Mandarin Chinese) used

          -  Participating in the investigation of another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuan Shen, M.D.,Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai 10th People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuan Shen, M.D.,Ph.D</last_name>
    <phone>2166303649</phone>
    <email>kmshy@tongji.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhongyong Shi, M.D</last_name>
    <phone>18701915271</phone>
    <email>szy0721@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai 10th People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200072</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanxia Guo, M.D.</last_name>
      <phone>021-65982875</phone>
      <email>guoyx_2000@tongji.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Vlisides P, Xie Z. Neurotoxicity of general anesthetics: an update. Curr Pharm Des. 2012;18(38):6232-40. Review.</citation>
    <PMID>22762477</PMID>
  </reference>
  <reference>
    <citation>Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010 Jul 28;304(4):443-51. doi: 10.1001/jama.2010.1013.</citation>
    <PMID>20664045</PMID>
  </reference>
  <reference>
    <citation>Gleason LJ, Schmitt EM, Kosar CM, Tabloski P, Saczynski JS, Robinson T, Cooper Z, Rogers SO Jr, Jones RN, Marcantonio ER, Inouye SK. Effect of Delirium and Other Major Complications on Outcomes After Elective Surgery in Older Adults. JAMA Surg. 2015 Dec;150(12):1134-40. doi: 10.1001/jamasurg.2015.2606.</citation>
    <PMID>26352694</PMID>
  </reference>
  <reference>
    <citation>Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014 Mar 8;383(9920):911-22. doi: 10.1016/S0140-6736(13)60688-1. Epub 2013 Aug 28. Review.</citation>
    <PMID>23992774</PMID>
  </reference>
  <reference>
    <citation>Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW; BRAIN-ICU Study Investigators. Long-term cognitive impairment after critical illness. N Engl J Med. 2013 Oct 3;369(14):1306-16. doi: 10.1056/NEJMoa1301372.</citation>
    <PMID>24088092</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2017</study_first_submitted>
  <study_first_submitted_qc>October 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Yuan Shen, MD, PhD</investigator_full_name>
    <investigator_title>Head of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>general anesthesia</keyword>
  <keyword>postoperative delirium</keyword>
  <keyword>postoperative cognitive dysfunction</keyword>
  <keyword>biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

